For research use only. Not for therapeutic Use.
Bafisontamab（Cat No.:I042166）is an investigational monoclonal antibody that targets the protein CD40, a co-stimulatory receptor found on immune cells like B-cells and dendritic cells. CD40 plays a crucial role in immune activation, and its interaction with its ligand (CD40L) helps to trigger immune responses, including those against tumors. By blocking CD40, bafisontamab aims to enhance the immune system’s ability to recognize and attack cancer cells. It is being studied in clinical trials for its potential to treat various cancers, particularly solid tumors, and improve patient outcomes through immune system modulation.
| Catalog Number | I042166 |
| CAS Number | 2437210-79-0 |
| Purity | ≥95% |
